Tafolecimab

Vendor: Abmole

Type: Antibodies

SKU: M24997

Explore specifications & documents
$218.50 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

Request a quotation
  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.
Tafolecimab

Tafolecimab

$218.50 USD

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Bioactivity
Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia.
Casnumber
2225109-03-3
Purity
≥98.0%
Target synonyms
IBI-306
Technical documents

Documents

Coa

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab